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Stepwise reprogramming of liver cells to a pancreas
progenitor state by the transcriptional regulator
Tgif2
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The development of a successful lineage reprogramming strategy of liver to pancreas holds
promises for the treatment and potential cure of diabetes. The liver is an ideal tissue source
for generating pancreatic cells, because of its close developmental origin with the pancreas
and its regenerative ability. Yet, the molecular bases of hepatic and pancreatic cellular
plasticity are still poorly understood. Here, we report that the TALE homeoprotein TGIF2 acts
as a developmental regulator of the pancreas versus liver fate decision and is sufficient to
elicit liver-to-pancreas fate conversion both ex vivo and in vivo. Hepatocytes expressing Tgif2
undergo extensive transcriptional remodelling, which represses the original hepatic identity
and, over time, induces a pancreatic progenitor-like phenotype. Consistently, in vivo forced
expression of Tgif2 activates pancreatic progenitor genes in adult mouse hepatocytes. This
study uncovers the reprogramming activity of TGIF2 and suggests a stepwise reprogramming
paradigm, whereby a ‘lineage-restricted’ dedifferentiation step precedes the identity switch.
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S
uccessful lineage reprogramming relies on the identification
of defined factor(s) able to establish the new cell fate
transcriptional program and, concomitantly, silence the
original gene expression program1–4. Here, we sought to
investigate cellular plasticity between liver and pancreas and to
what extent this enables their fate interconversion.
Lineage reprogramming holds distinct advantages over stem
cell-based replacement strategies, with the new cells being
autologous in origin, residing within their native tissue, and with
a theoretically lower risk of tumorigenesis5. Recent studies have
unveiled an unsuspected degree of cellular plasticity in the adult
pancreas and pointed to pancreas-resident cells as potential
sources for new b-cells6–15. However, from a clinical perspective,
adult liver cells hold important advantages over pancreatic
cells, representing a more accessible and abundant starting cell
population for fate conversion approaches to generate pancreatic
cells with therapeutic potential3,16. To date, adenovirus-mediated
ectopic expression of pancreatic transcription factors (TF)
(for example, Pdx1, Ngn3) in the liver has been shown to
partially correct hyperglycaemia in diabetic mice, even though the
phenotypic conversion appears incomplete17–20. Moreover,
delivery of the same pancreatic TFs through adeno-associated
viruses (AAV), which have low-immunogenity but high-
transduction efficiency, or upon transgene expression in mice
did not exert the same effects19,21,22. These observations are
consistent with the fact that the two lineages are closely related
but yet at a greater distance than cells of the same lineage, for
example, exocrine and endocrine pancreas cells23,24. Additional
limitations might be the lack of appropriate interaction partners
or the presence of antagonistic factors in liver cells that lock cell
identity, hampering cell plasticity and conversion. To overcome
these lineage restrictions, we investigated whether developmental
regulator(s) of the pancreas versus liver fate decision might be
effective reprogramming determinants for achieving conversion
of liver cells into pancreas fate.
The transcriptional mechanisms underlying hepatic and
pancreatic lineage divergence in the mouse embryo begin to be
unravelled25–27. In a RNASeq gene expression profile of liver and
pancreas progenitor cells isolated from the mouse embryo, we
identified the Three-Amino-acid-Loop-Extension (TALE)
homeobox TG-interacting factor 2 (TGIF2) at the cell-fate
branchpoint, being in the common endoderm progenitor pool
and whose expression changes in opposite directions as cells
commit to pancreatic or hepatic lineages25,28. TALE proteins are
involved in many crucial developmental processes and diseases
through their function as Hox-transcriptional co-regulators, but
also through Hox-independent mechanisms29,30. TGIF2 contains
a highly conserved homeodomain and has been described
as a context-independent transcriptional repressor, exerting its
function either through modulation of the BMP/TGF-beta
pathway or through direct DNA binding28,31. In Xenopus
embryos, Tgif2 acts as an intracellular endodermal effector
promoting pancreatic fate by inhibiting BMP signalling28. In the
mouse embryo, overlapping functions between Tgif2 and its close
family member, Tgif1, have been previously reported during
different embryological processes, such as gastrulation and neural
development32,33.
Here, we demonstrate that TGIF2 is a developmental regulator
of pancreas versus liver fate decision using both loss- and gain-of
function experiments in mouse embryos and embryonic stem
(ES) cells, respectively. In addition, when ectopically expressed in
murine adult liver cells, TGIF2 promotes suppression of the
hepatic transcriptional program and induction of a subset of
pancreatic genes. Overall, hepatocytes expressing Tgif2 acquire a
pancreatic progenitor state and upon exposure to pancreatic
microenvironment or in vivo transplantation into diabetic mice
the reprogrammed cells undergo further differentiation and
acquire certain functional pancreatic properties. Similarly, in vivo
AAV-mediated Tgif2 expression in adult mice turns on marker
genes of the pancreatic lineage in hepatocytes. In summary,
this study defines a novel strategy for controlled generation
of pancreatic progenitors based on TGIF2-dependent fate
conversion and opens to new investigation into the mechanistic
aspects of cellular identity and plasticity.
Results
Liver and pancreas fate divergence. The TALE class of
homeodomain-containing TFs are known to play crucial roles in
establishing cell identity and organogenesis, including pancreas
formation28,29,34. We found that foregut endoderm progenitors
express elevated Tgif2 levels, which is in line and validated
previous RNASeq data25 (Fig. 1a; Supplementary Fig. 1a).
Importantly, at the 2-somite (S) stage (E8.0) Tgif2 expression
was spatially confined to the caudo-lateral region of the ventral
foregut, which is the location of presumptive bipotent hepatic
and pancreas progenitors (Fig. 1c)35. Subsequently, by 7–9S
stage (E8.5), whole-mount immunofluorescence (IF) showed
co-localization of TGIF2 with PROX1 in ventral pancreatic
progenitors at the lip of the foregut but not in hepatoblasts
(Fig. 1b). After the fate decision between liver and pancreas is
made, Tgif2 exhibited high and persistent expression levels in
pancreas throughout embryonic development, as well as in
adulthood, whereas it was undetectable in the liver (Fig. 1;
Supplementary Fig. 1b,c).
Because of its restricted expression in the ventral foregut, we
asked whether Tgif2 regulates the allocation of foregut progenitor
cells into pancreas fate and is sufficient for the activation of
pancreatic transcriptional program. The closely related family
member, Tgif1, does not display a similar restricted expression,
being in both hepatic and pancreatic progenitor cells25. However,
given the high degree of functional overlap between Tgif2 and
Tgif1 during mouse embryogenesis29,33, we conditionally deleted
Tgif2 in the epiblast using a loxP-flanked Tgif2 allele36 and the
Sox2-Cre transgene37 in a Tgif1-deficient background32 (Fig. 2;
Supplementary Fig. 1d). No double homozygous mutant embryos
(Tgif2r/r;Tgif1 / ;Sox2-Cre) were found in our genetic
background (0 out of 216 embryos), hampering a complete
loss-of-function analysis (Supplementary Fig. 1d). However, the
presence of one single wild-type allele of either Tgif1 or Tgif2 gene
supported normal embryonic development to at least E10.5,
enabling the analysis of ventral foregut organogenesis (Fig. 2).
We analysed the expression of Pdx1 and Sox17, which is involved
in the segregation between liver and pancreatobiliary systems
and expressed in ventral pancreatic progenitors from E9.5
onward38–41. Interestingly, mouse embryos with Tgif combined
mutations, homozygous for one gene and heterozygous for the
other (for example, Tgif2r/þ ;Tgif1 / ;Sox2-Cre or Tgif2r/r;
Tgif1þ / ;Sox2-Cre), showed consistent reduction of the
SOX17þ and PDX1þ ventral pancreatic buds at E9.5
(Fig. 2a,b). This was accompanied by an expansion of the
hepatic bud volume, as measured by PROX1 staining (Fig. 2a,b).
Next, we directly assayed Tgif2 for pancreatic fate-inducing
activity. To model ex vivo endoderm development and specifica-
tion of pancreas progenitors, we used a directed stepwise
differentiation system of mouse embryonic stem cells (ESC),
adapted from previously published studies25,42,43. Monolayer
cultures of mES cells were first differentiated into definitive
endoderm (DE), transduced with a bicistronic lentiviral vector
(LV) expressing Tgif2 and the reporter enhanced green
fluorescent protein (EGFP) genes, and then differentiated into
pancreatic endoderm (PE) (Fig. 1d; Fig. 3a). We found that Tgif2
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14127
2 NATURE COMMUNICATIONS | 8:14127 |DOI: 10.1038/ncomms14127 | www.nature.com/naturecommunications
enhanced differentiation of the DE-induced population toward
pancreatic fate, as judged by the further increase in expression
levels of Sox17, Pdx1 and Hnf1b (Fig. 1d). Conversely, when DE
cells were differentiated into hepatic endoderm (HE)44 in the
presence of Tgif2, we observed marked decrease in the expression
of liver-specific genes (for example, Serpina1, Hnf4a, C/EBPa)
(Fig. 1d). Taken together, our results indicate that TGIF2 acts as a
developmental regulator of the hepatopancreatic lineage, pushing
foregut progenitors toward pancreatic cell fate and counteracting
hepatic fate. Thus, these properties make TGIF2 a pertinent
candidate to be tested for lineage reprogramming of liver to
pancreas.
Stepwise reprogramming of liver cells to pancreas progenitors.
To assess this possibility, first we developed an ex vivo lineage
reprogramming strategy based on LV vectors for stable and sus-
tained expression of Tgif2 in liver cells. We expressed Tgif2 in
primary mouse hepatocytes (HEP) that were freshly isolated from
adult livers and cultured in standard hepatocyte culture medium
(Fig. 3a; Supplementary Fig. 2e). At one week after transduction
with LV-TGIF2, we measured robust ectopic Tgif2 expression
and concomitant repression of liver-specific genes, including
Albumin, Serpina1 and Transthyretin (Ttr), and the TFs Hex,
Hnf4a andHnf4a1 liver-specific isoform (Fig. 3b). Two weeks post-
transduction, the depletion of hepatic transcripts was maintained
(Fig. 3b) and accompanied by induction of pancreatic progenitor
genes, such as the TFs Pdx1, Ptf1a, Neurod1, Pax6, MafA, Isl1, and
Insm1 (ref. 23), as well as Nestin, encoding an intermediate
filament protein, which marks undifferentiated pancreatic
precursor cells at E10.5 (ref. 45) (Fig. 3b; Supplementary Fig. 2f).
Notably, the expression of all these pancreatic TFs, besides Pdx1
and Ptf1a, begins at the onset of pancreatic bud formation by E10.5
and later is restricted to the endocrine cell population23,25. LV-
TGIF2 did not affect the expression levels of endogenous Tgif2 or
Tgif1 (Supplementary Fig. 2g).
Prolonged analysis of the LV-TGIF2-transduced cells beyond 2
weeks was not possible because of the limited viability of primary
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Figure 1 | TGIF2 controls pancreatic and hepatic cell lineage divergence. (a) RT-qPCR analysis of Tgif2 expression in the mouse foregut (fg) endoderm
and its derivatives, liver and pancreas. Data were normalized to that of Sdha and represented as fold change (FC) compared with liver samples (set to 1).
E8.5 fg was compared with E10.5 liver sample. Values shown are mean±s.e.m. (n¼ 3) *Po0.05. (b) TGIF2 (red) colocalizes with FOXA2 (green) in the
E7.5 mouse anterior DE and with PROX1 (green) in the E8.5 at the fg lip (see arrowhead). Arrow indicates prospective hepatic endoderm (HE). Inset panels
depict TGIF2 single channel image of the area in the dashed box. Embryos are presented in lateral view. Scale bars, 50mm. ht, heart; vpa, ventral pancreas.
(c) Left, whole-mount in situ hybridisation analysis of Tgif2 in 2S-stage mouse embryo. Embryo is presented in ventral view; arrow indicates lateral domains
of the ventral fg. Right, in situ hybridisation on E12.5 mouse cryosections detects expression of Tgif2 in the whole pancreatic epithelium (demarcated by
yellow dotted line). Scale bar, 50mm. pa, pancreas; st, stomach. (d) Schematic showing directed differentiation of mESC cultures into DE and, subsequently,
pancreatic (PE) or hepatic endoderm (HE). On day (d) 8 of differentiation, PE and HE populations were analysed by RT-qPCR for the expression of the
indicated genes in the presence or absence of LV-TGIF2. Induction of endogenous Tgif2 transcript was observed during directed differentiation of ESCs
toward endoderm, consistent with its expression profile in the gastrulating mouse embryo (b). Data were normalized to that of Sdha and shown as
Log2-expression ratio relative to control undifferentiated ES cultures. Serp., Serpina1. Values shown are mean±s.e.m. (n¼ 3). *Po0.05, **Po0.01 obtained
with REST randomization test63 for differentiated PE or HE versus undifferentiated ESC; #Po0.05, ##Po0.01 obtained for PE or HEþ LV-TGIF2 versus
non-transduced PE or HE.
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HEP cultures in vitro46,47. To overcome this problem, we used the
well-characterized non-transformed BAML hepatic cell line48, as
an additional ex vivo model system. The BAML is a cell line
established from adult wild-type mouse liver that was previously
shown to repopulate the liver in vivo48. This cell line displays
various mature hepatic features, including expression levels of
Albumin, Serpina1, Ttr, Fah, which are comparable to those in the
adult mouse liver (Supplementary Fig. 2a). However, the level of
important enzymes in glucose homoeostasis, such as G6pc and
Pepck, and members of the cytochrome P450 family, such as
Cyp3a11, is lower than in adult mouse liver, while biliary
epithelial markers Cytokeratin 7 and 19, are present in BAML,
like in bi-potential hepatic progenitor cells (Supplementary
Fig. 2a). We cultured the BAML hepatic cells in their standard
hepatocyte culture medium and characterized them after
transduction with either LV-TGIF2 or LV-GFP, as control, at
multiple time points ex vivo, as well as in vivo (Fig. 3c;
Supplementary Fig. 2b). Tgif2-expressing cells proliferated at a
lower rate than controls during the first week after transduction
and reacquired the normal proliferative activity after 10 days
(Supplementary Fig. 2c,d). At early time points (1 and 2 weeks),
ectopic Tgif2 expression in BAML HEP cells elicited effects
similar to those observed in primary HEPs, including strong
reduction of the hepatic gene expression program and subsequent
induction of a set of pancreatic genes (Fig. 3c). Importantly, the
levels of pancreatic transcripts either remained stably induced or
increased (for example, Pdx1 and MafA) over time (day (d) 30
and d50 time points after Tgif2 expression) (Fig. 3c). Repression
of the hepatic gene expression program was also maintained in
long-term cultures of LV-TGIF2-tranduced BAML HEP cells,
even though it became less prominent after d50, suggesting
possible occurrence of culture heterogeneity (Fig. 3c).
IF analysis corroborated these findings, showing LV-TGIF2-
transduced BAML HEP cells positive for GFP that were also
positive for SOX9 and/or PDX1 but displayed reduction or loss
of hepatic differentiation markers (albumin and glutamine
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Figure 2 | The TALE Tgif gene family controls lineage segregation within the ventral foregut endoderm of the mouse embryo. (a) Representative
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pancreatic buds and at E9.5 co-localized with SOX17 (green) in the pancreatobiliary progenitor population that gives rise to the ventral pancreas,
extrahepatic ducts, and gall bladder (arrow). PROX1 (blue) marked both liver and pancreatic buds. dpa, dorsal pancreas; lv, liver; r, recombined; vpa, ventral
pancreas. Scale bars, 50mm. (b) Quantification of the ventral pancreas and liver volume buds from confocal images of E9.5 embryos. Average fluorescence
intensity of PROX1þ liver buds, SOX17þ and PDX1þ ventral pancreas buds was measured using the ‘object analysis’ function in Huygens software. Error
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synthetase (GS)) (Fig. 3d). Three weeks after transduction, a
typical TGIF2-LV culture was composed of 50±4% SOX9-
positive cells, 8.75±1.23% PDX1-positive cells and
48.10%±3.84% of the PDX1-positive cells also co-express
SOX9. Notably, PDX1-positive cells were not simultaneously
positive for liver markers, such as albumin or GS, excluding
hybrid cellular phenotypes in LV-TGIF2 HEP cultures (Fig. 3d).
As expected, control BAML HEP cultures displayed typical
abundant cytoplasmic albumin or GS in the absence of pancreatic
markers (Fig. 3d).
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Figure 3 | Tgif2 expression induces adult murine liver cells to acquire molecular features of pancreatic progenitors. (a) Map of LVs and schematic
of the ex vivo reprogramming. Murine adult primary or BAML hepatocytes (HEP) were transduced with the constitutively active PGK-TGIF2-EGFP LV
(LV-TGIF2) expressing Tgif2 and EGFP, FACS-sorted for EGFP and characterized at different time points by various ex vivo and in vivo approaches.
(b) RT-qPCR analysis of hepatic and pancreatic gene expression in mouse primary HEPs at d7 and d14 after transduction with LV-TGIF2. Data were
normalized to Sdha and represented as Log2-expression ratio between LV-TGIF2-transduced and control hepatocytes at matched time-points. (c) RT-qPCR
analysis of hepatic and pancreatic gene expression in murine adult BAML HEP cells transduced with LV-TGIF2 at the indicated time points after
transduction. Data were normalized to Sdha and represented as Log2-expression ratio between LV-TGIF2-transduced and control cells. Values shown are
mean±s.e.m. (n¼ 5) *Po0.05. (d) IF of unsorted (no FACS) LV-TGIF2-transduced (right) BAML HEP cells and control cells (left). In top panel of
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cells that are ALB-negative in transduced cultures. In middle panels, arrows indicate examples of GFP-positive cells either PDX/SOX9-double or
PDX1/TGIF2-double positive cells. In bottom panel, asterisks (*) indicate Glutamine synthetase (GS)-positive cells (blue) that are negative for PDX1 (red)
in cultures d50 after transduction; open arrowheads (4) indicate PDX1-positive cells that are negative for GS. Scale bars, 50mm.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14127 ARTICLE
NATURE COMMUNICATIONS | 8:14127 |DOI: 10.1038/ncomms14127 | www.nature.com/naturecommunications 5
TFs in common between the two fates, such as Prox1 and
Foxa2, were expressed at similar levels in both control and
Tgif2-expressing HEP cells (Fig. 3c). Induction of marker genes
for stomach, duodenal and intestinal fates (for example, Sox2,
Nkx6.3 and Cdx2) was not detected in Tgif2-expressing HEP cells
(Fig. 3b,c; Supplementary Fig. 3a,b). Moreover, induction of
pancreatic fate was not accompanied by the activation of a
facultative liver stem/progenitor population (for example,
Lgr5-positive)49, pluripotency markers or other lineage-specific
transcripts, suggesting a fate-restricted switch (Fig. 3b;
Supplementary Fig. 3). Remarkably, we also observed induction
of endodermal genes, such as Gata6 and Cxcr4, as well as of Pdx1
and Ptf1a expression when LV-TGIF2 was transduced in adult
mouse fibroblasts, suggesting a potential broader reprogramming
activity of TGIF2 also in non-endodermal lineage cells
(Supplementary Fig. 3c).
Altogether these data show that Tgif2 is uniquely able to
rapidly down-regulate the typical hepatic gene regulatory network
and promote a pancreatic progenitor gene-expression signature
even in conditions that favour hepatic cell maintenance. We then
tested if LV-TGIF2-transduced primary HEPs grow and expand
in three-dimension (3D) culture conditions that have been
recently established for pancreas progenitor cells50. We found
that TGIF2-LV primary HEPs formed organoids, which were
composed of SOX9- and PDX1-positive cells (Fig. 4a,b). By
contrast, control non-transduced primary HEPs did not cluster to
form 3D aggregates under the same pancreatic conditions and
failed to grow (Fig. 4a). Next, to start testing the differentiation
potentials of the organoids established from TGIF2-LV primary
HEPs, we transplanted them into fresh E12.5 mouse pancreatic
explants (Fig. 4c). Importantly, when exposed to their native
pancreatic microenvironment, the grafted progenitor cells
(GFP-positive) either expressed pancreatic progenitor markers
(PDX1, NKX6.1) or retained the potential to differentiate
and expressed acinar (AMYLASE) or endocrine (INSULIN,
GLUCAGON) markers (Fig. 4c). Endocrine differentiation
of GFP-positive grafted progenitor cells was more frequent into
glucagonþ cells, resulting in average of B30% GLUCþ /GFPþ
versus 10% INSþ /GFPþ , while exocrine cells were less frequent
(Fig. 4c). Altogether, these results indicate that in the presence of
TGIF2 mature hepatocytes acquire a typical pancreatic progenitor
gene expression signature and can further differentiate as true
GFP NKX6.1 PDX1 Hoe GFP AMYLASE Hoe GFP GLUC INS Hoe
GFP PDX1 SOX9 Hoe Hoe PDX1 SOX9
CTRL LV-TGIF2 LV-TGIF2 LV-TGIF2
a
b
c
Figure 4 | Primary hepatocytes transduced with LV-TGIF2 formed pancreatic organoid structures. (a) Micrographs of primary HEPs grown in
three-dimension (3D) culture conditions for E10.5 mouse pancreas progenitor cells. Control (CTRL) primary hepatocytes failed to grow in the same
conditions. All organoid structures shown in the figure were generated from LV-TGIF2-transduced primary hepatocytes. Bar, 100mm. (b) IF staining on
cryosections of LV-TGIF2-organoids for GFP (green), SOX9 (blue) and PDX1 (red). Hoechst (Hoe) nuclear counterstain in grey. Scale bar, 20 mm.
(c) Whole-mount IF staining of pancreatic explants transplanted with LV-TGIF2-organoids. Insets are magnifications of the areas in the white boxes and
shown as single channel images. Left panel, arrows indicate GFP-positive grafted cells that are positive for PDX1 and NKX6.1 (n¼6, IF exp.). Middle panel,
arrow indicates GFP-positive cell that is amylase-positive (n¼ 5, IF exp.). Right panel, arrows indicate GFP-positive grafted cells expressing endocrine
markers, insulin or glucagon (n¼6, IF exp.). Dashed yellow line marks pancreatic epithelium. Scale bar, 50mm.
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progenitor cells. Reprogrammed primary and BAML HEP cells
are hereafter referred to as TGIF2-induced Pancreatic Progenitor
(TiPP) cells.
Tgif2-reprogramming induces gene expression remodelling.
Next, we analysed the changes in global gene expression in
reprogrammed TiPP cells. We compared the gene expression
profiles of FACS-purified TiPP cells at two time points (d14 and
d30 post-transduction), control BAML HEP cells, mouse
embryonic pancreas (E14.5) and adult pancreas and liver tissues.
Unsupervised hierarchical clustering of gene expression data
showed a clear relationship between reprogrammed TiPP cells
and E14.5 mouse pancreas (Fig. 5a). As expected, the control
BAML HEP population clustered together with adult liver
(Fig. 5a). Notably, typical representative genes, which define
pancreatic progenitor identity, including Sox9, Pdx1, Pax6, Cpa1,
Nr5a2, Neurod1, Tead2, Tle2, Tle3, were upregulated in TiPP
cells, whereas all well-known genes involved in hepatic functions,
such as cytochrome enzymes, apolipoproteins and detoxification
enzymes, were down-regulated (Fig. 5b).
Embryonic pancreas and liver share many common features,
which is reflected by the similarity of their transcriptome
profiles24 (Supplementary Fig. 4). To measure to what extent
TiPP cells are closer to pancreatic or hepatic progenitors,
we first focused on the initial events of reprogramming (at d14
time point) and examined the overlap between the gene
expression-signature of mouse E10.5 FACS-purified pancreatic
and hepatic progenitors25, TiPP d14 and control population
transcriptomes (Supplementary Fig. 4a,b). We found that more
than 50% of the pancreas progenitor genes were upregulated in
TiPP d14 cells, indicating a significant overlap (FC42, P value
o0.05, Benjamini–Hochberg method) despite the methodological
differences (Supplementary Fig. 4a). By contrast, only 4% of E10.5
hepatic genes were upregulated in TiPP cells (FC42, P value
o0.05) (Supplementary Fig. 4b). Similarly, the comparison of the
expression profiles of reprogrammed cells with mouse embryonic
liver and pancreas at later stages (E13.5–E14.5) showed that TiPP
cells gained a larger fraction of pancreatic-specific markers
compared with hepatoblast-specific markers (Supplementary
Fig. 4c,d). Thus, the reprogramming event was broadly reflected
in global gene expression changes, suggesting that TiPP cells are
similar to mouse pancreatic progenitors.
Analysis of gene ontology terms enrichment of differentially
regulated TiPP genes revealed an upregulation for genes involved
in developmental processes, cell adhesion and transcription, while
genes involved in metabolic and transport processes were
downregulated (Supplementary Fig. 4f; Supplementary Data 1).
This is in line with the robust inhibition of typical hepatocyte
functions (Fig. 5b). Interestingly, the analysis of enrichment of
Panther pathway annotations pointed to genes involved in the
Wnt signalling pathway (23 genes; P value, 0.00043) (Fig. 5c).
In particular, we found that many Wnt/Planar cell polarity core
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genes, such as Vangl, Celsr, Prickle1 and Scrib, as well as
downstream Wnt transducers, such as Tcf7, Nfatc2, Camk2b and
Tle3, were upregulated in reprogrammed cells (Fig. 5d,e). These
findings are consistent with the previously recognized role for
non-canonical Wnt in pancreas and liver cell lineage divergence
and imply concurrent changes in epithelial cell polarity during
liver-to-pancreas fate conversion, as seen in the embryo25,51.
Finally, since TGIF2 is a known regulator of TGF-b and BMP
signalings28,33, we searched for potential modulation of their
target genes in TiPP and control population transcriptomes.
We observed a strong downregulation of well-known direct BMP
targets (Id1 and Id2) in TiPP cells, while the effect on TGF-b
target genes is less prominent (Supplementary Fig. 4e). These
findings are consistent with previous reports on TGIF
transcriptional regulation of BMP/TGF-b signalling28,33 and
the role of BMP in pancreas versus liver fate decision24.
Induced pancreatic progenitors differentiate in vivo. A strin-
gent test routinely used for pancreatic progenitor cells obtained
in vitro is whether they ‘mature’ to functional cells when
implanted in vivo42,43. To assess the in vivo differentiation
potential of the reprogrammed-derived pancreatic progenitors,
we engrafted the TiPP cells (1 106 cells) under the kidney
capsule (KC) of hyperglycemic Akita mice. Islets from Akita
heterozygous mice are depleted of b-cells, and those remaining
release very little mature insulin, representing an excellent mouse
model of diabetes52. We found that blood glucose levels improved
soon after transplantation of TiPP cells and remained stable over
the eight weeks duration of the experiment (Fig. 6a), displaying
an effect comparable to the transplantation of 100–200 mouse
islet equivalent (IE) (Supplementary Fig. 5). IF analysis revealed
that TiPP cells implanted under the KC organized themselves
into epithelial structures, which were positive for PDX1 and
SOX9 or for typical molecular features of pancreatic b-cells,
such as GLUT2, insulin, C-peptide, prohormone convertase (PC)
2 and urocortin 3 (UCN3) (Fig. 6b; Supplementary Fig. 5e). In
particular, within the grafts B30% INS-positive cells were
detected, (29±2%), reflecting the efficiency of differentation of
TiPP cells upon engraftment. By contrast, neither amylase nor
other endocrine hormones were detected in the grafted TiPP cells
(Supplementary Fig. 5d). Akita mice transplanted with BAML
HEP cells transduced with control LV-GFP displayed higher
levels of glycaemia throughout the assay and did not acquire
pancreatic differentiation features in the KC mesenchyme
(Fig. 6a,b; Supplementary Fig. 5). No tumours were observed
after eight weeks posttransplantation. These results indicate that
pancreatic progenitors derived from reprogrammed hepatic cells
are ‘poised’ for further differentiation along the endocrine b-cell
lineage when exposed to the appropriate environment.
Nevertheless, the obtained insulin-producing cells are likely
immature beta-like cells and do not fully recapitulate functional
capacity of mature beta-cells.
In vivo induction of pancreas progenitors. Given its remarkable
ex vivo reprogramming activity, we next assessed whether TGIF2
might induce a pancreatic program in vivo directly in the
native liver environment. To exclusively target hepatocytes,
we ectopically expressed Tgif2 using recombinant AAV2/8 vector,
100
200
300
400
500
600 GFP
TiPP
a
b
Weeks
Bl
oo
d 
gl
uc
os
e 
le
ve
ls 
(m
g d
l–1
)
–2 –1 1 2 3 4 5 6 7 80
HEP+LV-GFP
PDX1 SOX9 GFP 
INS GFP Hoe 
TiPP cells
TiPP cellsTiPP cells
SOX9 GFP Hoe
SOX9 GFP Hoe 
TiPP cells TiPP cells
TiPP cells
C-PEP GFP Hoe PC2 GFP Hoe 
GLUT2 GFP Hoe UCN3 GFP Hoe 
**
TiPP cells
Figure 6 | In vivo analysis of TGIF2 reprogramming activity.
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under the KC of hyperglycemic Akita mice (red line). Animals engrafted
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which exhibits hepatocyte-specific tropism and rapid clearance,
and combined it with the hepatocyte-specific thyroid-binding
globulin (TBG) promoter53 (Fig. 7a). Livers from adult animals
administered with AAV8.TBG-Tgif2 were collected at different
time points after delivery and examined for cellular identity by
RT-qPCR and IF analyses (Fig. 7a–c; Supplementary Figs 6–8).
Normal tissue-architecture was preserved in AAV-injected livers,
as judged by their lobular organization along the porto-central
axis and distinct periportal and perivenous gene expression
patterns (Fig. 7c; Supplementary Figs 6 and 7). Notably, within
one week of AAV8.TBG-Tgif2 injection, we detected ectopic
SOX9-positive cells throughout the liver parenchyma (Fig. 7c,d),
including in the perivenous ‘zone 3’ of the liver that is close to the
central vein and positive for GS, whereas in adult livers under
normal conditions SOX9 marks only biliary epithelial cells
(bec)26,49,54,55 (Fig. 7c). Ectopic SOX9 activation in hepatocytes
of AAV8.TBG-Tgif2-injected livers was not accompanied by
expression of bec markers (for example, Epcam, Osteopontin and
CK19)47,53,54, excluding the induction of biliary fate (Fig. 7c;
Supplementary Fig. 7a). One month post-AAV injection, we
observed induction of PDX1 expression in a subset (18%) of
SOX9-positive cells as well as additional pancreatic TFs, such as
NeuroD1 and Nkx6.1 (Fig. 7c,d), but neither endocrine nor
exocrine differentiation functions (Supplementary Fig. 7b) in the
livers of AAV8.TBG-Tgif2-injected animals. AAV injection itself
(for example, AAV.GFP) did not induce ectopic activation of
pancreatic genes in hepatocytes (Fig. 7c,d; Supplementary
Fig. 6c). Next, we asked whether environmental cues, such
as a hyperglycemic state, might promote maturation of the
Tgif2-induced pancreatic progenitor-like cells in vivo too.
AAV8.TBG-Tgif2 was injected into diabetic Akita heterozygous
mice, blood glucose levels and insulin concentration were
measured at d60 after AAV delivery (Supplementary Fig. 6e,f).
While blood glucose levels remained elevated in non-treated and
AAV.GFP-injected Akita mice, a group of AAV.TGIF2-treated
Akita animals (4 out 7) showed sustained decrease in blood
glucose, which was accompanied by higher levels of circulating
insulin (Supplementary Fig. 6e,f). The others remained
hyperglycemic with low insulin levels. Altogether, these results
indicate that ectopically expressed TGIF2 exerts similar activity
in vivo, being sufficient to induce typical pancreatic progenitor
genes expression, during normal adult liver homoeostasis.
Discussion
Our data show that TGIF2 functions as a versatile reprogram-
ming factor, exerting a twofold activity: it unlocks and represses
hepatic identity and establishes pancreatic cell identity. Hepatic
cells undergoing fate switching pass through an intermediate state
that lacks characteristics of both the initial and final cellular
identities, a so-called dedifferentiation step. Importantly,
we found that this intermediate state is not widely plastic and
Tgif2-expressing cells are instead ‘lineage-restricted’ toward the
pancreatic progenitor fate, without reverting to pluripotency or
switching to other closely related lineages. Moreover, given the
fact that adult hepatocytes are differentiated and arrested in
quiescence (G0 phase), the change in cell identity triggered by
Tgif2 occurs in the absence of cell division (Supplementary
Fig. 8), possibly implying a direct fate transitioning through
discrete steps.
Previous liver-to-pancreas reprogramming studies used
adenovirus vectors to force the expression of pancreatic TFs
(for example, Pdx1, Ngn3) in the liver in vivo or hepatic cell
cultures17,18,20. These studies mostly focused on the acquisition of
insulin expression and some other markers of pancreatic identity,
but they did not assess the degree of loss of hepatic fate and did
not follow the fate transition (liver to pancreas) temporally.
Importantly, in the strategy presented here, we showed that
TGIF2 first represses hepatic gene expression, which is followed
by induction of pancreatic progenitor genes. Such temporal
succession of the events is a prerequisite to avoid aberrant hybrid
cellular states in lineage reprogramming. In addition, in previous
studies the forced expression of pancreatic TFs seems to work
only under certain conditions that might be favourable to cellular
transdifferentiation17,18,20. For instance, adenovirus-mediated
delivery of Pdx1 or Ngn3 was shown to induce insulin
expression by the liver, whereas AAV-mediated overexpression
of the same TFs did not result into insulin production or
correction of diabetes in mice19. These observations suggest that
adenoviruses may facilitate cellular reprogramming, possibly
because of their ability to induce general inflammatory responses,
which is instead absent upon AAV gene transfer19,56.
It is therefore crucial to assess the exact contribution of the
reprogramming factor(s) itself in the absence of an inflammatory
microenvironment. For this reason, in our novel strategy we
assessed the specific reprogramming activity of TGIF2 using
independent in vivo and ex vivo approaches and different delivery
methods, including AAV under liver homoeostasis.
TGIF2 has been characterized as a context-independent
transcriptional repressor, being able to exert its function either
through modulation of the BMP/TGF-beta pathway or direct
DNA binding28,29,31. Interestingly, the transcriptome analysis of
the TiPP cells shows a higher number of upregulated than
downregulated genes (470 out of 592 differentially regulated
genes; Po0.01, FCo 4 or 44). If TGIF2 acts solely as a
repressor, one possible mechanism of action to achieve activation
of so many genes would be through the repression of a repressor.
Alternatively, TGIF2 may function simultaneously as both an
activator and repressor of genes during reprogramming.
This is indeed a common feature of other TALE homeoproteins
to act both as transcriptional repressor or activator in a
context-dependent manner, for example, depending on
cellular environment and binding partners29,30. Systematic
characterization of TGIF2-mediated transcriptional activity will
establish if this is the case also for this homeoprotein.
Reprogramming of hepatic cells to a pancreatic identity
presents a valuable model to study hepatopancreatic plasticity
and to identify by which mechanism each fate is established and
maintained. Consistently, we identified a subset of molecular
networks that are activated both in TGIF2-induced reprogram-
ming as well as during liver and pancreas fate decision in the
embryo. For instance, the enrichment of numerous non-canonical
Wnt players in TiPP cells is consistent with the RNA-Seq
profiling of mouse pancreatic and hepatic progenitor cells
at the time of their lineage divergence25. In addition to Wnt
modulation, we found robust and stable upregulation of Fgfr1
and some of its well-known downstream signal transducers,
including Akt3, Plcg2, Mapk12, in the reprogrammed TiPP
cells when compared with control hepatocytes (Supplementary
Table 1). Recent observations identified a regulatory loop between
SOX9 and FGF signalling in the early pancreatic niche that is
required to repress liver-specific gene expression program and
ensure pancreatic fate identity at early time point57. Thus, our
findings suggest that TGIF2 may install a similar circuit between
SOX9 and Fgfr in hepatocytes that undergo reprogramming,
recapitulating the same in vivo mechanisms. Notably, we also
found induction of the transcription factor Tead2 in TiPP cells at
early stage of reprogramming. This is in in line with the Teads
being pancreatic progenitor-enriched factors in the mouse
embryo25 and human pancreatic progenitors58, where they
act as integral components of the pancreatic lineage-specific
transcriptional program, regulating SOX9 and FGF receptors58.
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From a broader perspective, the reported TGIF2-mediated
stepwise fate conversion affords a unique opportunity to decipher
genetic and epigenetic changes during the intermediate states of
liver-to-pancreas reprogramming. This might also shed light on
more fundamental reprogramming mechanisms. Indeed, fate
conversion via a ‘tissue-restricted’ dedifferentiation step, which
precedes re-differentiation into the new cell type, has been
reported in natural transdifferentiation events in worms59, as well
as during limb regeneration in the axolotl (ref. 60), suggesting
possible common themes in reprogramming and regeneration
across phyla. The knowledge gained from these experimental
manipulations will have broad implications not only for
understanding the molecular basis of cellular identity and
plasticity, but also for potential clinical application. Ultimately,
the stepwise TGIF2-dependent fate conversion represents a novel
strategy for controlled generation of pancreatic progenitors from
liver and, possibly, a starting point for future production of
pancreatic b-cells suitable for therapeutic use in diabetic patients.
Methods
Cell culture and viral infection. Mouse ES cells (R1 line)61 were maintained on
gelatin-coated plates with inactivated mouse embryonic fibroblasts (MEFs) in
standard mESC medium (High Glucose DMEM (Invitrogen) supplemented with
15% Fetal Calf Serum (FCS) Gold Serum (PAA), non-essential amino acids
(Invitrogen), 1% Penicillin/Streptomycin (Invitrogen), 10mM sodium pyruvate
(Invitrogen), 1% Glutamax (Invitrogen), 50 mm 2-mercaptoethanol (Invitrogen))
and 1,000Uml 1 leukaemia inhibitory factor (ESGRO). For differentiation,
cultures were MEF-depleted and seeded in mESC medium at high-confluence on
gelatin-coated dishes. Monolayer differentiation was carried out as following42,43:
DE medium to day 2 consisted of RPMI medium (Invitrogen) and 0.2% FCS
supplemented with 50 ngml 1 Activin A and 25 ngml 1 Wnt3a at day 1 and
Activin A only at day 2. PE medium to day 8 consisted of RPMI medium and 2%
FBS supplemented with 3 ngml 1 Wnt3a and 50 ngml 1 FGF10 (refs 42,43). HE
medium to day 8 consisted of RPMI medium and 2% FBS supplemented with 1%
B27, 10 ngml 1 basic FGF and 20 ngml 1 BMP4 (ref. 44). All recombinant
proteins were purchased from R&D System unless otherwise stated. Plateable male
mouse CD-1 cryopreserved primary hepatocytes (Life Technologies) and BAML
cells were cultured on Collagen I-coated plates in hepatocyte medium48 (referred to
as ‘HEP medium’), which consists of William’s E medium without phenol red
(Sigma), 1% Penicillin/Streptomycin, 1% Glutamax, 10% FCS, 30 ngml 1 IGF II
(Peprotech), 50 ngml 1 EGF (R&D), 10mgml 1 Insulin (Peprotech), 0.1 mm
dexamethasone and 10mM nicotinamide. Mouse adult fibroblast cultured were
established from tail biopsies and cultured in DMEM supplemented with 10% FCS.
Cell lines were routinely tested for normal karyotype and mycoplasma. Cells
were infected with pPGK-TGIF2-2A-EGFP lentiviral expression vector
(LV-TGIF2) at multiplicity of infection (MOI) of 40. The pPGK-TGIF2-2A-EGFP
lentiviral expression vector (LV-TGIF2) was generated by cloning the
cDNAs of mouse Tgif2 and EGFP, linked by the T2A self-cleaving sequence,
into the pRRL.SIN.cPPT.PGK-GFP.WPRE lentiviral plasmid vector
(Addgene plasmid 12252).
FACS experiments. For FACS isolation, hepatic cell suspensions were first filtered
through a BD Falcon tube with cell strainer cap (BD 352235). Before sorting,
propidium iodide (PI) was added to exclusively select live cells. After dead cell
exclusion (SSC-A/PI-A), GFP-expressing cells were sorted using a FACS Aria I
flow cytometer (BD Biosciences) using a GFP filter and setting the gate on the GFP
fluorescence intensity. For cell cycle analysis, cells were fixed in 70% ethanol
overnight and incubated with 100 mgml 1 RNase A and 40mgml 1 PI for 30min
at 37 C. The cell cycle profile was analysed using the BD LSRFortessa cell analyser.
For generation of the growth curve, cells were seeded on collagen-coated plates on
day 12 post-transduction at a density of 2.5 104 cells per well. The medium was
changed daily, and the cell number was counted every day for one week.
3D culture and transplantation assay in explants. For 3D-differentiation50
control primary hepatocytes or after transduction with LV-TGIF2 were dissociated
and about 8–10 cells per ml mixed with Matrigel (BD Biosciences) at a ratio 1:3 and
plated in pancreas progenitors culture conditions50. For transplantation assay into
pancreatic explants, LV-TGIF2-organoids after 6 days in culture were roughly
dissociated in 0.05% trypsin and injected into the recipient explants with a mouth
pipette. E12.5 pancreatic explants were isolated and cultured as described in ref. 62.
After engraftment, the explants were cultured for 4 days, fixed in 4%
paraformaldehyde and analysed by immunofluorescent staining. The experiment
was repeated twice with a total of 28 TGIF2-organoids successfully grafted into
recipient pancreatic explants63.
Immunohistochemistry and in situ hybridisation. Mouse embryos and tissues
were fixed in 4% paraformaldehyde at 4 C from 2 h to overnight. For
cryosectioning, samples were equilibrated in 20% sucrose solution and embedded
in OCT compound (Sakura). Whole-mount in situ hybridisation and in situ
hybridisation on cryostat sections (10mm) were performed according to ref. 28. For
whole-mount immunostainings fixed mouse embryos were bleached for 1–2 h in
6% hydrogen peroxide solution, incubated in freshly prepared PBSMT blocking
solution (2% milk powder, 0,5% TritonX-100 in 1 PBS), and afterwards with
primary antibodies at the appropriate dilution ON at 4 C (see Supplementary
Table 2). After extensive washes in fresh PBSMT solution at least 5–8 times, the
embryos were incubated overnight with secondary antibodies at 4 C in PBSMT
solution25,64. Whole mouse embryos from E 9.5 onward were cleared in methyl
salicylate for confocal microscope imaging. For immunostaining, cryosections were
incubated with TSA (Perkin-Elmer) blocking buffer for 1 h at room temperature
and afterwards with primary antibodies at the appropriate dilution (Supplementary
Table 2). If necessary, antigen retrieval was performed by boiling the slides for
20min in citrate buffer (Dako). For IF on cultured cells, cells were grown on
coverslips, fixed in 4% paraformaldehyde for 20min at RT and permeabilised in
0.2% Triton X-100 in PBS. Images were acquired on Zeiss AxioObserver and Zeiss
LSM 700 laser scanning microscope. Huygens software (SVI) was used for 3D
volume measurement analysis of confocal z-stacks of mouse embryos. For
quantification of SOX9 and PDX1-positive cells, one entire lobe of AAV-injected
and uninjected livers were sectioned, sampled at a minimum of every 150 mm and
processed by immunohistochemistry. Liver sections were acquired using tile scan
(mosaic) function on a Zeiss LSM 700 laser scanning microscope, cells were
counted from digitized micrographs and area (Hoechst-positive) measured using
ImageJ or Axiovision softwares. Sections were counted from at least three animals
per condition. Values presented are the average cell number relative to the area of
liver section (mm2). Student’s t-test was used for statistical analysis.
RT-qPCR and transcriptome analysis. RNA was isolated using RNAzol (Biozol)
or High Pure RNA Isolation Kit (Roche). Total RNA was processed for reverse
transcription (RT) using Transcriptor First Strand cDNA Synthesis Kit (Roche).
Real-time PCR reactions were carried out using the SYBR Green Master Mix
(Roche) on ABI StepOne Plus system. Succinate dehydrogenase (SDHA) or 36B4
were used as reference genes. Primer sequences are provided in Supplementary
Table 1. Technical triplicates were run for all samples and ‘no RT’ and no template
controls were included in all experiments. All the values were normalized to the
reference genes and calculated using the software REST63. qPCRs were performed
for 40 cycles. ‘Undetermined’ data points were assigned a Ct of ‘40’ to enable
calculation of fold change. Also, reactions with Ct-values equal to the ‘no RT’
control reaction were considered as ‘negative’ and the values used for calculating
fold changes. Statistical significance in qPCR experiments was calculated using the
REST randomization test63. Whole transcriptome analysis was performed on
Agilent SurePrint G3 Mouse GE 8 60 K Microarray Kits at the MPI Array
Facility, Dresden. The single colour signals were read using Agilent Feature
Extraction Software. All bioinformatics analyses were performed using R
(http://www.r-project.org). Differential gene expression was determined using the
R statistical package limma65. Expression values were scaled per row by Z-score
(row average equals zero (white); positive or negative values indicate how many
standard deviations the value is located above (red) or below (blue) the mean,
respectively). Adjusted P values were corrected for multiple testing using the
Benjamini–Hochberg method. Gene Ontology analysis was performed using the
Genecodis application66.
Mouse strains. C57BL/6-Ins2Akita/J (ref. 52), TGIF1tm1aPah (ref. 51) and
Tg(Sox2-cre)1Amc/J (ref. 37) (JAX laboratories) mouse strains were previously
described. The mouse TGIF2tm1a(EUCOMM)Wtsi strain was generated at the ICS
using the EUCOMM embryonic stem (ES) cell collection36. All animal
experimentation was carried out in accordance to the local ethics committee for
animal care.
Transplantation underneath the kidney capsule. Spontaneously diabetic
8–9 weeks old C57BL/6-Ins2Akita/J female mice were used as recipients.
100–200 mouse IE or 1 106 FACS-sorted cells were collected and transplanted
under the kidney capsule, according to previously reported procedures67. Blood
glucose was measured at 12 h intervals over the first two days post-transplantation
and biweekly thereafter. After 8 weeks, the graft-bearing kidneys were removed and
fixed overnight in 4% formalin at RT. Samples were embedded in paraffin for
histological analysis.
AAV experiments. The adeno-associated viral construct AAV8.TBG.TGIF2 was
generated by cloning mouse Tgif2 cDNA into the pENN.AAV2/8.TBG.PI.RBG
plasmid vector (PennVector p1015). Replication-incompetent AAV8.TBG.TGIF2
and AAV8.TBG.eGFP AAVs were produced at the Penn Vector Core facility.
2–4 1011 particles of adeno-associated virus diluted in sterile PBS were
administered per adult mouse (C57BL/6 and C57BL/6-Ins2Akita/J strains) by tail
vein injection.
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Glucose tolerance test. Glucose tolerance test (GTT) was carried out on animals
that had been fasted overnight, before the day of experimentation (time point  1).
Animals were injected i.p. with glucose (2 g kg 1 body weight). Glucose levels were
measured from blood collected from the tail immediately before the glucose
challenge (time point 0) and 15, 30, 60, 120 and 240min after the glucose injection
using a blood glucose metre (Contour, Bayer). Serum insulin concentration was
measured with the Ultra Sensitive Mouse Insulin ELISA kit (Crystal Chem.
#90080).
Statistical tests. All results are expressed as mean±s.e. (s.e.m.). Sample sizes
of at least n¼ 3 were used for statistical analyses except where indicated. The
significance of differences between groups was evaluated by two-tailed unpaired
Student’s t-test or, when more than two groups were assessed, by ANOVA test.
Po0.05 was considered statistically significant. Statististical tests relevant to
the qPCR and microarray experiments are described in the ‘RT-qPCR and
transcriptome analysis’ section.
Data availability. Gene expression data have been deposited in GEO (Gene
Expression Omnibus) under accession code GSE54591. The authors declare that all
other data supporting the findings of this study accompany the article and its
Supplementary Information Files, or are available from the corresponding author
on reasonable request.
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